Amy C. Peterson's Net Worth
$66.9 Million
Who is Amy C. Peterson?
Amy C. Peterson has an estimated net worth of $66.9 Million. This is based on reported shares across multiple companies, which include BeiGene, Ltd., CytomX Therapeutics, Inc., and EXELIXIS, INC..
SEC CIK
Amy C. Peterson's CIK is 0001682735
Past Insider Trading and Trends
2018 was Amy C. Peterson's most active year for acquiring shares with 7 total transactions. Amy C. Peterson's most active month to acquire stocks was the month of January. 2018 was Amy C. Peterson's most active year for disposing of shares, totalling 41 transactions. Amy C. Peterson's most active month to dispose stocks was the month of October. 2018 saw Amy C. Peterson paying a total of $1,746,000.00 for 414,744 shares, this is the most they've acquired in one year. In 2018 Amy C. Peterson cashed out on 845,769 shares for a total of $8,457,291.67, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
BeiGene, Ltd. (BGNE) Snapshot price: $191.32
CMO, Immuno-oncology
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$81.39 | -$2,091,536.07 |
0
|
Scheduled
|
Dec 17 - Dec 18
| ||
Form 4
|
—
|
0
|
$74.65 | -$3,644,089.13 |
0
|
Scheduled
|
Nov 8 - Nov 12
| ||
Form 4
| -100.00% | -5.77K |
$169.12 | -$975,666.46 |
0
|
Scheduled
|
Aug 23
| ||
Form 4
| +19.81% | 44.56K |
—
|
—
| 269.57K |
Jun 26
| |||
Form 4
| -100.00% | -3.60K |
$82.96 | -$298,747.11 |
0
|
Scheduled
|
Nov 13
| ||
Form 4
| -9.40% | -28.18K |
$5.39 | -$151,829.78 | 271.81K |
Aug 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
∞
| 300K |
—
|
—
| 300K |
Aug 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CytomX Therapeutics, Inc. (CTMX) Snapshot price: $1.2
EVP, Chief Development Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -6.79% | -4.26K |
$1.98 | -$8,424.60 | 58.43K |
Mar 16
| |||
Form 4
| +25.00% | 12.54K |
$1.42 | -$10,612.39 | 62.69K |
Jul 19 - Jul 20
| |||
Form 4
| +622.96% | 40K |
—
|
—
| 46.42K |
Feb 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 24
| |||
Form 4
| +107.06% | 3.32K |
$6.09 | $20,205.52 | 6.42K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 26
| |||
Form 4
|
∞
| 3.1K |
$6.39 | $19,821.59 | 3.1K |
Nov 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EXELIXIS, INC. (EXEL) Snapshot price: $25.13
EVP Prod Dev & Med Aff & CMO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +34.22% | 82.12K |
—
|
—
| 322.12K |
Feb 23
| |||
Form 4
|
∞
| 240K |
—
|
—
| 240K |
Aug 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||